Table 1 Demographic characteristics of the participants at baseline
Variables | Gothenburg | Umeå | Total |
|---|---|---|---|
Subjects, N | 22 | 15 | 37 |
Females, n (%) | 12 (55%) | 7 (47%) | 19 (51%) |
Males, n (%) | 10 (45%) | 8 (53%) | 18 (49%) |
Age, yr (mean ± SD) | 44 ± 10 | 47 ± 13 | 48 ± 15 |
Height, cm (mean ± SD) | 175 ± 9 | 172 ± 9 | 171 ± 8 |
Weight, kg (mean ± SD) | 79 ± 18 | 78 ± 16 | 77 ± 15 |
Body mass index, kg/m2 (mean ± SD) | 26 ± 4 | 26 ± 6 | 26 ± 5 |
Birch pollen allergy, n (%) | 22 (100%) | 15 (100%) | 37 (100%) |
Asthma Control Questionnaire (mean ± SD) | 1.3 ± 1.1 | 1.3 ± 1.2 | 1.3 ± 1.1 |
Self-reported medication a | |||
Short-acting bronchodilator, n (%) | 18 (82%) | 6 (40%) | 24 (65%) |
Long-acting medication, n (%) | 2 (9%) | 2 (13%) | 4 (11%) |
Inhalation steroids medication, n (%) | 19 (86%) | 6 (40%) | 25 (68%) |
Nasal steroid, n (%) | 7 (32%) | 2 (13%) | 9 (24%) |
Steroid medication (Inhalation and combination steroids), n (%) | 19 (86%) | 8 (53%) | 27 (73%) |
Allergy medicine, n (%) | 22 (100%) | 11 (73%) | 33 (89%) |